{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:10Z","timestamp":1792791010521,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Medical University Undergraduate Innovation and Entrepreneurship Training Program","award":["GDMU2023355"],"award-info":[{"award-number":["GDMU2023355"]}],"id":[{"id":"https:\/\/ror.org\/04k5rxe29","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["A2023290"],"award-info":[{"award-number":["A2023290"]}]},{"name":"The Clinical and Basic Science Innovation Special Program of Guangdong Medical University","award":["GDMULCJC2024054"],"award-info":[{"award-number":["GDMULCJC2024054"]}],"id":[{"id":"https:\/\/ror.org\/04k5rxe29","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2022A1515012195"],"award-info":[{"award-number":["2022A1515012195"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhanjiang Science and Technology Plan Project","award":["2021A05091"],"award-info":[{"award-number":["2021A05091"]}]},{"name":"High-level talents scientific research start-up funds of the Affliated Hospital of Guangdong Medical University","award":["2020123465"],"award-info":[{"award-number":["2020123465"]}],"id":[{"id":"https:\/\/ror.org\/04k5rxe29","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08945-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:41:24Z","timestamp":1752576084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Developing angiogenesis-related prognostic biomarkers and therapeutic strategies in bladder cancer using deep learning and machine learning"],"prefix":"10.1038","volume":"15","author":[{"given":"Yutong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"8945_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9, 58 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"8945_CR2","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran, A., Cookson, M. S., Guercio, B. J. & Cheng, L. Advances in diagnosis and treatment of bladder cancer. BMJ 384, e076743 (2024).","journal-title":"BMJ"},{"key":"8945_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters, A., Aben, K. K. H. & Kiemeney, L. The global burden of urinary bladder cancer: an update. World J. Urol. 38, 1895\u20131904 (2020).","journal-title":"World J. Urol."},{"key":"8945_CR4","doi-asserted-by":"publisher","first-page":"105152","DOI":"10.1016\/j.ebiom.2024.105152","volume":"104","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer. EBioMedicine 104, 105152 (2024).","journal-title":"EBioMedicine"},{"key":"8945_CR5","doi-asserted-by":"publisher","first-page":"843077","DOI":"10.3389\/fimmu.2022.843077","volume":"13","author":"X Qing","year":"2022","unstructured":"Qing, X. et al. Molecular characteristics, clinical significance, and cancer immune interactions of angiogenesis-associated genes in gastric cancer. Front. Immunol. 13, 843077 (2022).","journal-title":"Front. Immunol."},{"key":"8945_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s13402-021-00602-3","volume":"44","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor, J. & Mortezaee, K. Angiogenesis as a hallmark of solid tumors-clinical perspectives. Cell. Oncol. (Dordr) 44, 715\u2013737 (2021).","journal-title":"Cell. Oncol. (Dordr)"},{"key":"8945_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","volume":"7","author":"Z Fu","year":"2022","unstructured":"Fu, Z., Li, S., Han, S., Shi, C. & Zhang, Y. Antibody drug conjugate: the biological missile for targeted cancer therapy. Signal. Transduct. Target. Ther. 7, 93 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"8945_CR8","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/j.ejps.2022.106324","volume":"181","author":"D Vemula","year":"2023","unstructured":"Vemula, D., Jayasurya, P., Sushmitha, V., Kumar, Y. N. & Bhandari, V. CADD, AI and ML in drug discovery: A comprehensive review. Eur. J. Pharm. Sci. 181, 106324 (2023).","journal-title":"Eur. J. Pharm. Sci."},{"key":"8945_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"8945_CR10","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng, R. et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 47, D729\u2013d735 (2019).","journal-title":"Nucleic Acids Res."},{"key":"8945_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","volume":"16","author":"A Beck","year":"2017","unstructured":"Beck, A., Goetsch, L., Dumontet, C. & Corva\u00efa, N. Strategies and challenges for the next generation of antibody-drug conjugates. Nat. Rev. Drug Discov. 16, 315\u2013337 (2017).","journal-title":"Nat. Rev. Drug Discov"},{"key":"8945_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","volume":"64","author":"M Alas","year":"2021","unstructured":"Alas, M., Saghaeidehkordi, A. & Kaur, K. Peptide-drug conjugates with different linkers for cancer therapy. J. Med. Chem. 64, 216\u2013232 (2021).","journal-title":"J. Med. Chem."},{"key":"8945_CR13","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672-d677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"8945_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"8945_CR15","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.7150\/ijbs.80017","volume":"19","author":"H Zheng","year":"2023","unstructured":"Zheng, H. et al. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. Int. J. Biol. Sci. 19, 4689\u20134708 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"8945_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41597-023-02709-8","volume":"10","author":"S Gul","year":"2023","unstructured":"Gul, S. et al. Stemness signature and targeted therapeutic drugs identification for triple negative breast Cancer. Sci. Data. 10, 815 (2023).","journal-title":"Sci. Data"},{"key":"8945_CR17","doi-asserted-by":"publisher","first-page":"803355","DOI":"10.3389\/fimmu.2022.803355","volume":"13","author":"H Lu","year":"2022","unstructured":"Lu, H., Wu, J., Liang, L., Wang, X. & Cai, H. Identifying a novel defined Pyroptosis-Associated long noncoding RNA signature contributes to predicting prognosis and tumor microenvironment of bladder Cancer. Front. Immunol. 13, 803355 (2022).","journal-title":"Front. Immunol."},{"key":"8945_CR18","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher, P., Cox, N. & Huang, R. S. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 9, e107468 (2014).","journal-title":"PLoS One"},{"key":"8945_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12967-025-06243-6","volume":"23","author":"F Zhao","year":"2025","unstructured":"Zhao, F., Chen, M., Wu, T., Ji, M. & Li, F. Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD. J. Transl Med. 23, 222 (2025).","journal-title":"J. Transl Med."},{"key":"8945_CR20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10495-023-01868-8","volume":"28","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis 28, 1423\u20131435 (2023).","journal-title":"Apoptosis"},{"key":"8945_CR21","doi-asserted-by":"publisher","first-page":"118058","DOI":"10.1016\/j.jep.2024.118058","volume":"328","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Bao Yuan Decoction alleviates fatigue by restraining inflammation and oxidative stress via the AMPK\/CRY2\/PER1 signaling pathway. J. Ethnopharmacol. 328, 118058 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"8945_CR22","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Kushenol O regulates GALNT7\/NF-\u03baB axis-Mediated M2 macrophage polarization and efferocytosis in papillary thyroid carcinoma. Phytomedicine\u00a015:6373. (2025).","DOI":"10.1016\/j.phymed.2025.156373"},{"key":"8945_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade. Cell. Rep. 18, 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"key":"8945_CR24","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. iMLGAM: integrated machine learning and genetic Algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. Imeta 4, e70011 (2025).","journal-title":"Imeta"},{"key":"8945_CR25","first-page":"32","volume":"96","author":"C Liang","year":"2025","unstructured":"Liang, C. et al. Hypericin photoactivation induces triple-negative breast cancer cells pyroptosis by targeting the ROS\/CALR\/Caspase-3\/GSDME pathway. J. Adv. Res. 96, 32 (2025).","journal-title":"J. Adv. Res."},{"key":"8945_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","volume":"31","author":"J Fucikova","year":"2021","unstructured":"Fucikova, J., Spisek, R., Kroemer, G. & Galluzzi, L. Calreticulin and cancer. Cell. Res. 31, 5\u201316 (2021).","journal-title":"Cell. Res."},{"key":"8945_CR27","doi-asserted-by":"publisher","first-page":"830688","DOI":"10.3389\/fonc.2022.830688","volume":"12","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. RNA-Binding protein COL14A1, TNS1, NUSAP1 and YWHAE are valid biomarkers to predict peritoneal metastasis in gastric Cancer. Front. Oncol. 12, 830688 (2022).","journal-title":"Front. Oncol."},{"key":"8945_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","volume":"611","author":"A Ca\u00f1ellas-Socias","year":"2022","unstructured":"Ca\u00f1ellas-Socias, A. et al. Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells. Nature 611, 603\u2013613 (2022).","journal-title":"Nature"},{"key":"8945_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omto.2021.12.026","volume":"24","author":"CK Huang","year":"2022","unstructured":"Huang, C. K., Sun, Y., Lv, L. & Ping, Y. ENO1 and Cancer. Mol. Ther. Oncolytics. 24, 288\u2013298 (2022).","journal-title":"Mol. Ther. Oncolytics"},{"key":"8945_CR30","doi-asserted-by":"crossref","unstructured":"Wang, L., Wang, Y., Wang, J., Li, L. & Bi, J. Identification of a prognosis-related risk signature for bladder cancer to predict survival and immune landscapes. J Immunol Res 201:3236384. (2021).","DOI":"10.1155\/2021\/3236384"},{"key":"8945_CR31","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/jcmm.14082","volume":"23","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Hu, L., Zheng, Y. & Guo, L. HMGA1 in cancer: Cancer classification by location. J. Cell. Mol. Med. 23, 2293\u20132302 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"8945_CR32","first-page":"14","volume":"33","author":"A Cazes","year":"2022","unstructured":"Cazes, A., Childers, B. G., Esparza, E. & Lowy, A. M. The MST1R\/RON tyrosine kinase in cancer: Oncogenic functions and therapeutic strategies. Cancers (Basel) 33, 14 (2022).","journal-title":"Cancers (Basel)"},{"key":"8945_CR33","first-page":"13","volume":"96","author":"P Zhang","year":"2025","unstructured":"Zhang, P. et al. Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J. Immunother. Cancer 96, 13 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"8945_CR34","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1002\/biof.2142","volume":"51","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. Navigating the immune landscape with plasma cells: A pan-cancer signature for precision immunotherapy. Biofactors 51, e2142 (2025).","journal-title":"Biofactors"},{"key":"8945_CR35","first-page":"15","volume":"84","author":"Y Li","year":"2025","unstructured":"Li, Y., Song, X., Huang, Y., Zhou, S. & Zhong, L. Genetic associations of plasma metabolites with immune cells in hyperthyroidism revealed by Mendelian randomization and GWAS-sc-eQTLs xQTLbiolinks analysis. Sci. Rep. 84, 15 (2025).","journal-title":"Sci. Rep."},{"key":"8945_CR36","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood, B., Najafi, M. & Mortezaee, K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review. J. Cell. Physiol. 234, 8509\u20138521 (2019).","journal-title":"J. Cell. Physiol."},{"key":"8945_CR37","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/2326-6066.CIR-19-0826","volume":"8","author":"MM Leblond","year":"2020","unstructured":"Leblond, M. M. et al. CD40 agonist restores the antitumor efficacy of Anti-PD1 therapy in Muscle-Invasive bladder Cancer in an IFN I\/II-Mediated manner. Cancer Immunol. Res. 8, 1180\u20131192 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"8945_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41590-021-00896-3","volume":"22","author":"M Takahashi","year":"2021","unstructured":"Takahashi, M. et al. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-\u03b2 pathway. Nat. Immunol. 22, 485\u2013496 (2021).","journal-title":"Nat. Immunol."},{"key":"8945_CR39","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"8945_CR40","first-page":"13","volume":"89","author":"AU Kabir","year":"2021","unstructured":"Kabir, A. U. et al. Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity. Sci. Transl. Med. 89, 13 (2021).","journal-title":"Sci. Transl. Med."},{"key":"8945_CR41","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.4049\/jimmunol.2000574","volume":"205","author":"Z Lu\u017enik","year":"2020","unstructured":"Lu\u017enik, Z., Anchouche, S., Dana, R. & Yin, J. Regulatory T cells in angiogenesis. J. Immunol. 205, 2557\u20132565 (2020).","journal-title":"J. Immunol."},{"key":"8945_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41418-021-00880-2","volume":"29","author":"S Hu","year":"2022","unstructured":"Hu, S. et al. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-\u03b2-catenin-STAT3 signaling. Cell. Death Differ. 29, 642\u2013656 (2022).","journal-title":"Cell. Death Differ."},{"key":"8945_CR43","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan, Y., Yu, Y., Wang, X. & Zhang, T. Tumor-Associated macrophages in tumor immunity. Front. Immunol. 11, 583084 (2020).","journal-title":"Front. Immunol."},{"key":"8945_CR44","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1002\/jcb.27646","volume":"120","author":"M Najafi","year":"2019","unstructured":"Najafi, M. et al. Macrophage Polarity in cancer: A review. J. Cell. Biochem. 120, 2756\u20132765 (2019).","journal-title":"J. Cell. Biochem."},{"key":"8945_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro, B., Sarobe, P., Herv\u00e1s-Stubbs, S. & Melero, I. Advances in immunotherapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18, 525\u2013543 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8945_CR46","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.7150\/thno.53649","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu, J. et al. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics 11, 3089\u20133108 (2021).","journal-title":"Theranostics"},{"key":"8945_CR47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer. 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"8945_CR48","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.7150\/thno.74281","volume":"12","author":"N Zhang","year":"2022","unstructured":"Zhang, N. et al. Machine learning-based identification of tumor-infiltrating immune cell-associated LncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma. Theranostics 12, 5931\u20135948 (2022).","journal-title":"Theranostics"},{"key":"8945_CR49","doi-asserted-by":"publisher","first-page":"15607","DOI":"10.1002\/jcp.28208","volume":"234","author":"J Hu","year":"2019","unstructured":"Hu, J. et al. The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets. J. Cell. Physiol. 234, 15607\u201315618 (2019).","journal-title":"J. Cell. Physiol."},{"key":"8945_CR50","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout, J. A. et al. Spatial positioning and matrix programs of Cancer-Associated fibroblasts promote T-cell exclusion in human lung tumors. Cancer Discov. 12, 2606\u20132625 (2022).","journal-title":"Cancer Discov"},{"key":"8945_CR51","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2174\/0929867329666220819122205","volume":"30","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Zhan, Y., Liu, C. & Zhan, W. Application of machine learning technology in the prediction of ADME- related Pharmacokinetic parameters. Curr. Med. Chem. 30, 1945\u20131962 (2023).","journal-title":"Curr. Med. Chem."},{"key":"8945_CR52","doi-asserted-by":"publisher","first-page":"1008865","DOI":"10.3389\/fimmu.2022.1008865","volume":"13","author":"Z Chang","year":"2022","unstructured":"Chang, Z. et al. Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients. Front. Immunol. 13, 1008865 (2022).","journal-title":"Front. Immunol."},{"key":"8945_CR53","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.7150\/thno.82492","volume":"13","author":"S Pan","year":"2023","unstructured":"Pan, S. et al. FN1 mRNA 3\u2019-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3\u2019-UTR-let-7i-5p-THBS1 axis. Theranostics 13, 5130\u20135150 (2023).","journal-title":"Theranostics"},{"key":"8945_CR54","doi-asserted-by":"publisher","first-page":"1000321","DOI":"10.3389\/fimmu.2022.1000321","volume":"13","author":"Z Xiao","year":"2022","unstructured":"Xiao, Z., Cai, Z., Deng, D., Tong, S. & Zu, X. An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer. Front. Immunol. 13, 1000321 (2022).","journal-title":"Front. Immunol."},{"key":"8945_CR55","doi-asserted-by":"publisher","first-page":"9147","DOI":"10.1038\/s41598-025-93674-2","volume":"15","author":"B Li","year":"2025","unstructured":"Li, B. et al. Comprehensive analysis of RNA methylation-related genes to identify molecular cluster for predicting prognosis and immune profiles in bladder cancer. Sci. Rep. 15, 9147 (2025).","journal-title":"Sci. Rep."},{"key":"8945_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-024-01963-7","volume":"23","author":"K Liu","year":"2024","unstructured":"Liu, K. et al. A review of the clinical efficacy of FDA-approved antibody\u2013drug conjugates in human cancers. Mol. Cancer. 23, 62 (2024).","journal-title":"Mol. Cancer"},{"key":"8945_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","volume":"21","author":"K Tsuchikama","year":"2024","unstructured":"Tsuchikama, K., Anami, Y., Ha, S. Y. Y. & Yamazaki, C. M. Exploring the next generation of antibody-drug conjugates. Nat. Rev. Clin. Oncol. 21, 203\u2013223 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"8945_CR58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12272-023-01447-0","volume":"46","author":"R Maiti","year":"2023","unstructured":"Maiti, R. et al. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities. Arch. Pharm. Res. 46, 361\u2013388 (2023).","journal-title":"Arch. Pharm. Res."},{"key":"8945_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phymed.2018.09.174","volume":"50","author":"X Li","year":"2018","unstructured":"Li, X., Li, X., Huang, N., Liu, R. & Sun, R. A comprehensive review and perspectives on Pharmacology and toxicology of saikosaponins. Phytomedicine 50, 73\u201387 (2018).","journal-title":"Phytomedicine"},{"key":"8945_CR60","doi-asserted-by":"publisher","first-page":"1162540","DOI":"10.3389\/fphar.2023.1162540","volume":"14","author":"A Zhang","year":"2023","unstructured":"Zhang, A. et al. Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma. Front. Pharmacol. 14, 1162540 (2023).","journal-title":"Front. Pharmacol."},{"key":"8945_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0300-483X(97)03631-7","volume":"119","author":"E Benfenati","year":"1997","unstructured":"Benfenati, E. & Gini, G. Computational predictive programs (expert systems) in toxicology. Toxicology 119, 213\u2013225 (1997).","journal-title":"Toxicology"},{"key":"8945_CR62","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1021\/acs.chemrestox.5b00531","volume":"29","author":"B Bhhatarai","year":"2016","unstructured":"Bhhatarai, B., Wilson, D. M., Parks, A. K., Carney, E. W. & Spencer, P. J. Evaluation of TOPKAT, toxtree, and Derek Nexus in Silico models for ocular irritation and development of a Knowledge-Based framework to improve the prediction of severe irritation. Chem. Res. Toxicol. 29, 810\u2013822 (2016).","journal-title":"Chem. Res. Toxicol."},{"key":"8945_CR63","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/jox12040027","volume":"12","author":"S Manoharan","year":"2022","unstructured":"Manoharan, S., Deivendran, B. & Perumal, E. Chemotherapeutic potential of Saikosaponin D: Experimental evidence. J. Xenobiot 12, 378\u2013405 (2022).","journal-title":"J. Xenobiot"},{"key":"8945_CR64","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1080\/13880209.2021.1992448","volume":"59","author":"P Zhou","year":"2021","unstructured":"Zhou, P. et al. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics. Pharm. Biol. 59, 1480\u20131489 (2021).","journal-title":"Pharm. Biol."},{"key":"8945_CR65","doi-asserted-by":"publisher","first-page":"114408","DOI":"10.1016\/j.biopha.2023.114408","volume":"161","author":"A Samantasinghar","year":"2023","unstructured":"Samantasinghar, A. et al. A comprehensive review of key factors affecting the efficacy of antibody drug conjugate. Biomed. Pharmacother. 161, 114408 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"8945_CR66","doi-asserted-by":"publisher","first-page":"113815","DOI":"10.1016\/j.fct.2023.113815","volume":"177","author":"TT Tang","year":"2023","unstructured":"Tang, T. T. et al. Saikosaponin D exerts cytotoxicity on human endometrial cancer Ishikawa cells by inducing apoptosis and inhibiting metastasis through MAPK pathways. Food Chem. Toxicol. 177, 113815 (2023).","journal-title":"Food Chem. Toxicol."},{"key":"8945_CR67","doi-asserted-by":"publisher","first-page":"152100","DOI":"10.1016\/j.acthis.2023.152100","volume":"125","author":"Y Wu","year":"2023","unstructured":"Wu, Y., Zhang, J., Wang, X., Xu, Y. & Zheng, J. Saikosaponin-d regulates angiogenesis in idiopathic pulmonary fibrosis through angiopoietin\/Tie-2 pathway. Acta Histochem. 125, 152100 (2023).","journal-title":"Acta Histochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08945-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:51:41Z","timestamp":1757253101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8945"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08945-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The published version of the manuscript has been read and approved by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors state that this study was conducted without commercial or financial relationships that could be interpreted as potential conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets analyzed during this study are available in the TCGA and GEO databases at\n                      \n                      and\n                      \n                      . The collected data used in the research are available from the corresponding author upon enquiry. The illustrations used in the workflow diagrams are from Bioicons (\n                      \n                      ) and are used with permission.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing and data accessibility"}}],"article-number":"25534"}}